NYU Langone Wins $70M to Fast-Track Medical Breakthroughs

NYU Langone Health just won nearly $70 million to help scientists get lifesaving discoveries out of the lab and into patients' hands faster than ever before.

The seven-year grant from the National Institutes of Health will fund the university's Clinical and Translational Science Institute, which acts like a research superhighway. It helps doctors and scientists skip the roadblocks that usually slow down medical progress.

The institute gives researchers access to tools most departments could never afford on their own. That includes patient data systems, clinical trial networks, expert statisticians, and training programs for young scientists just starting their careers.

Since 2009, the institute has supported nearly 5,000 research projects. More than half were led by early-career investigators, turning the program into a launching pad for the next generation of medical innovators.

Those projects have generated over 1,500 new grants and 1,500 published studies. The research has led to real improvements in patient care, public health programs, and health policies that affect communities across the country.

"This award positions NYU Langone at the forefront of translational science," said Dr. Miriam Bredella, who directs the institute. "We are building the infrastructure to move discoveries into real-world patient care faster and at scale."

The Ripple Effect

The timing couldn't be better for New York City's diverse population. NYU Langone's network stretches across Family Health Centers, NYC public hospitals, and all 11 schools and colleges of New York University.

That reach transforms the entire city into a living laboratory where discoveries can be tested across different communities. It means breakthroughs developed in Manhattan labs can quickly reach patients in the Bronx, Brooklyn, and beyond.

The new funding will expand the work even further over the next seven years. Priorities include deepening partnerships with communities, making health data tools more accessible, and speeding up how quickly clinical trials can start and finish.

The grant also focuses on training researchers at every career stage. That investment means more scientists will have the skills to bridge the gap between laboratory discoveries and treatments that actually help patients.

Dr. Dafna Bar-Sagi, NYU Langone's chief scientific officer, emphasized the ultimate goal: "The CTSI is a critical institutional engine that allows us to turn scientific discovery into better care for patients across New York City and beyond."

The institute's track record shows what's possible when researchers get the support they need, and this funding promises to accelerate that progress for thousands more patients waiting for tomorrow's treatments.